In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase

NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases

(2014) A. Jain et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli

(2014) Arne Søraas et al.   PLoS One

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

(2013) F. Jansaker et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum  -lactamase-producing Escherichia coli

(2012) N. Lampri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media

(2011) J. D. Perry et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae

(2011) Emilia Titelman et al.   Microbial Drug Resistance